Related Experiment Video
Updated: Feb 17, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
16.4K
Computational systems biology approaches for Parkinson's disease
1Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 7 avenue des Hauts Fourneaux, L-4362, Esch-sur-Alzette, Luxembourg. enrico.glaab@uni.lu.
Cell and Tissue Research
|November 30, 2017
Summary
Computational systems biology offers new ways to understand Parkinson's disease (PD) by modeling complex genetic and environmental factors. This approach aims to improve diagnosis and develop targeted therapies for PD patients.
Area of Science:
- Computational biology
- Systems biology
- Neuroscience
Background:
- Parkinson's disease (PD) is a complex, heterogeneous neurological disorder with diverse motor and non-motor symptoms.
- Multiple genetic and environmental factors contribute to PD pathogenesis, necessitating a holistic understanding beyond isolated risk factors.
Purpose of the Study:
- To review computational systems biology approaches for studying multifactorial molecular alterations in complex disorders, focusing on Parkinson's disease.
- To discuss the application of pathway analysis and machine learning techniques to PD omics data.
- To propose strategies for integrating diverse biological data sources for enhanced PD research.
Main Methods:
- Review of computational systems biology methodologies.
- Analysis of cellular pathway and network analysis techniques.
- Evaluation of multivariate machine learning approaches for omics data integration.
Main Results:
- Systems biology offers a framework to model the combinatorial effects of multiple molecular changes in PD.
- Different computational approaches have varying strengths and weaknesses for analyzing PD-related omics data.
- Integrating multiple biological knowledge and data sources can yield synergistic insights.
Conclusions:
- Computational systems biology is crucial for a comprehensive understanding of Parkinson's disease mechanisms.
- Advanced analytical methods are needed to interpret complex omics data in PD.
- Translating systems biology findings into clinical applications, such as diagnostics and therapeutics, presents significant opportunities and challenges.
Related Concept Videos
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K

